跳至主要内容
临床试验/NCT04741048
NCT04741048撤回不适用

A Pre-market, Open-label Feasibility, Prospective, Single-arm Multicenter Feasibility Investigation of Hearing Performance Using the CI624 in Adults With Low-frequency Residual Hearing.

Cochlear2 个研究点 分布在 1 个国家开始时间: 2021年3月8日最近更新:
适应症

试验速览

阶段
不适用
状态
撤回
发起方
Cochlear
试验地点
2
主要终点
Characterize hearing performance of the CI624.

研究概览

简要总结

The purpose of the feasibility study is to investigate hearing performance (audiometry and speech perception) using the CI624 in a group of adults (n=15) with low-frequency residual hearing who meet inclusion criteria.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
18 Years 至 70 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years-of-age or older at the time of surgery.
  • Low-frequency threshold at 500 Hz ≤ 50 dB HL and high-frequency pure-tone average (PTA), 2000-8000 Hz ≥ 65 dB HL in the ear to be implanted.
  • Pure-tone average (PTA) (0.5k, 1k, 2k Hz) > 30 dB HL in the contralateral ear.
  • CNC word recognition scores (mean of two lists) ≤ 60% in the ear to be implanted and ≤ 80% in the contralateral ear.
  • English spoken as a primary language.
  • Willing and able to provide written informed consent.

排除标准

  • Individuals older than 70 years at the time of surgery.
  • Duration of severe to profound sensorineural hearing loss > 20 years per self-report.
  • Onset of sensorineural hearing loss, for the purpose of this study, prior to 5 years-of-age.
  • Ossification or any other cochlear anomaly that might prevent complete insertion of the electrode array.
  • Conductive overlay of 15 dB or greater at two or more frequencies, in the range of 250 through 1000 Hz in the ear to be implanted.
  • Hearing loss of neural or central origin.
  • Diagnosis of Auditory Neuropathy.
  • Active middle-ear infection.
  • Medical or psychological conditions that contraindicate undergoing surgery as determined by the Investigator.
  • Unrealistic expectations on the part of the subject, regarding the possible benefits, risks, and limitations that are inherent to the device and/or procedure, as determined by the Investigator.
  • Additional handicaps that would prevent or restrict participation in the audiological evaluations as determined by the Investigator.
  • Unable or unwilling to comply with the requirements of the clinical investigation as determined by the Investigator.
  • Investigator site personnel directly affiliated with this study and/or their immediate family (spouse, parent, child, or sibling).
  • Cochlear employees or employees of a Contract Research Organization (CRO) or contractors engaged by Cochlear for the purposes of this investigation.
  • Currently participating, or has participated in the last 30 days, in another interventional clinical investigation/trial involving an investigational drug or device.

结局指标

主要结局

Characterize hearing performance of the CI624.

时间窗: 14 months

Hearing performance of the CI624 will characterized using Constant Nucleus Constant (CNC) word recognition in quiet. Performance is scored as percent correct words.

次要结局

未报告次要终点

研究者

发起方
Cochlear
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Hearing Implant Performance in Adults With... | 临床试验